Merck unloaded stake in Moderna earlier this quarter

 

• "Merck (NYSE:MRK) achieved a substantial gain on its direct holding in Moderna (NASDAQ:MRNA) over the life of the investment, particularly in 2020 given the substantial appreciation in Moderna's stock price," says the company in a statement.
• Merck had invested a sizable amount in Moderna in 2018 via a preferred-equity stake.
• A $20 stock at the start of 2020, Moderna nearly touched $180 earlier this week after positive results from its Covid-19 vaccine candidate. Shares pulled back to $141 yesterday. If Merck sold in the first half of Q4, that would mean a price somewhere between roughly $70 and $100.
• https://seekingalpha.com/news/3640755-merck-unloaded-stake-in-moderna-earlier-this-quarter